FOFQX
Price
$10.55
Change
+$0.01 (+0.09%)
Updated
Jun 30 closing price
Net Assets
816.58M
MSVAX
Price
$10.35
Change
+$0.01 (+0.10%)
Updated
Jun 30 closing price
Net Assets
347.8M
Interact to see
Advertisement

FOFQX vs MSVAX

FOFQX vs MSVAX Comparison Chart in %
View a ticker or compare two or three
VS
FOFQX vs. MSVAX commentary
Jul 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOFQX is a Hold and MSVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FOFQX has more cash in the bank: 817M vs. MSVAX (348M). FOFQX (3.36) and MSVAX (3.23) have matching dividends . FOFQX was incepted earlier than MSVAX: FOFQX (8 years) vs MSVAX (42 years). MSVAX (0.90) is less costly to investors than FOFQX (0.81). FOFQX is a more actively managed with annual turnover of: 16.43 vs. MSVAX (9.00). MSVAX initial investment is less costly to investors than FOFQX (4%) vs FOFQX (4%). FOFQX (1000) and MSVAX (1000) have matching initial minimum investment requirements. MSVAX (7.20) and FOFQX (7.15) have marching annual gain over last year. MSVAX return over 5 years is better than : 2.54 vs. FOFQX (-0.85).
FOFQXMSVAXFOFQX / MSVAX
Total Expense Ratio0.810.8299%
Annual Report Gross Expense Ratio0.810.9090%
Fund Existence8 years42 years-
Gain YTD2.2202.129104%
Front Load4%4%88%
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets817M348M235%
Annual Yield % from dividends3.363.23104%
Returns for 1 year7.157.2099%
Returns for 3 years11.2511.05102%
Returns for 5 years-0.852.54-33%
Returns for 10 yearsN/A14.32-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFIPX30.79N/A
N/A
Franklin Global Equity A
ETIHX58.38N/A
N/A
Eventide Healthcare & Life Sciences I
TICIX45.14N/A
N/A
Timothy Plan Israel Common Values I
RYIMX24.66N/A
N/A
Guggenheim Multi-Hedge Strategies I
PIIDX17.44N/A
N/A
Principal International Equity R-6